MAP2 Antikörper
Kurzübersicht für MAP2 Antikörper (ABIN361345)
Target
Alle MAP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Specific for endogenous levels of the ~280 kDa MAP2 protein.
-
Kreuzreaktivität
- Rind (Kuh), Human, Maus, Ratte
-
Sensitivität
- The antibody has been directly tested for reactivity in bovine, human, mouse and rat. It is expected that the antibody will react with other mammalian tissues.
-
Produktmerkmale
- Our Anti-Microtubule Associated Protein 2 (MAP2) Antibody primary antibody is chicken polyclonal. It detects Microtubule Associated Protein 2 (MAP2) and is total igy fraction. It is great for use in ELISA, WB, IHC, ICC.
-
Aufreinigung
- Total IgY fraction.
-
Immunogen
- Recombinant bovine MAP2 protein expressed in and purified from E. Coli.
-
Isotyp
- IgY
-
-
-
-
Applikationshinweise
-
Dilution Range: ICC: 1:1000-1:20,000
Dilution Range: WB: 1:20000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 19 mg/mL
-
Buffer
- PBS + 10 mM Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Recommended that the undiluted antibody be aliquoted into smaller working volumes (10-30 uL/vial depending on usage) upon arrival and stored long term at -20° C or -80° C, while keeping a working aliquot stored at 4° C for short term. Avoid freeze/thaw cycles. Stable for at least 1 year.
-
Haltbarkeit
- 12 months
-
-
-
: "Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders." in: Scientific reports, Vol. 12, Issue 1, pp. 902, (2022) (PubMed).
: "Structural deficits in key domains of Shank2 lead to alterations in postsynaptic nanoclusters and to a neurodevelopmental disorder in humans." in: Molecular psychiatry, (2022) (PubMed).
: "Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus." in: Molecular autism, Vol. 11, Issue 1, pp. 85, (2021) (PubMed).
: "Truncating mutations in SHANK3 associated with global developmental delay interfere with nuclear β-catenin signaling." in: Journal of neurochemistry, (2020) (PubMed).
: "GluA2 mRNA distribution and regulation by miR-124 in hippocampal neurons." in: Molecular and cellular neurosciences, Vol. 61, pp. 1-12, (2014) (PubMed).
-
: "Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders." in: Scientific reports, Vol. 12, Issue 1, pp. 902, (2022) (PubMed).
-
- MAP2 (Microtubule-Associated Protein 2 (MAP2))
-
Andere Bezeichnung
- MAP2
-
Hintergrund
-
Synonyms: DKFZp686I2148 antibody, MAP 2 antibody, MAP dendrite specific antibody, MAP-2 antibody, MAP2 antibody, MAP2A antibody, MAP2B antibody, MAP2C antibody, Microtubule associated protein 2 antibody, Microtubule-associated protein 2 antibody, MTAP2_HUMAN antibody
Description Logic: Our Anti-Microtubule Associated Protein 2 (MAP2) Antibody primary antibody is chicken polyclonal. It detects Microtubule Associated Protein 2 (MAP2) and is total igy fraction. It is great for use in ELISA, WB, IHC, ICC.
Gene Name Alternatives: MAP2
-
Molekulargewicht
- 280 kDa
-
Gen-ID
- 4133
-
UniProt
- P11137
Target
-